









Markets
/
Stocks
/
nasdaq-smlr
/

Semler Scientific Inc

SMLR

29.490USD

+1.810+6.54%

Close 09/18, 16:00（ET）Quotes delayed by 15 min

403.67MMarket Cap

10.90P/E TTM



Semler Scientific Inc

29.490

+1.810+6.54%

Overview Company Financials Analysis

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

TradingKey Stock Score

Currency: USD Updated: 2025-09-18

Key Insights

The company's fundamentals are relatively stable. Its valuation is considered fairly valued,and institutional recognition is very high. Over the past 30 days, multiple analysts have rated the company as a Buy. Despite a good stock market performance and outperforming fundamentals, the technicals don't support the current trend. The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Industry Ranking

67 / 207

Overall Ranking

179 / 4721

Industry

Healthcare Equipment & Supplies

Support & Resistance

No Data

Score Analysis

Current score

Previous score

Analyst Rating

Based on 3 analysts

Buy

Current Rating

85.333

Target Price

+208.29%

Upside Space

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Company Highlights

StrengthsRisks

Semler Scientific, Inc. develops, manufactures, and markets products and services that assist in evaluating and treating chronic diseases. The Company provides technology solutions to healthcare providers. The Company's flagship product, QuantaFlo is a four-minute in-office blood flow test. Healthcare providers can use blood flow measurements as part of their examinations of a patient’s vascular condition, including assessments of patients who have vascular disease. QuantaFlo features a sensor clamp that is placed on the toe or finger. Infrared light emitted from the clamp on the dorsal surface of the digit is scattered and reflected by the red blood cells coursing through the area of illumination. Returning light is sensed by the sensor. A blood flow waveform is instantaneously constructed by its proprietary software algorithm. Its customers for QuantaFlo include insurance plans, physician groups, risk assessment groups, hospitals and retailers.

Growing

The company is in a growing phase, with the latest annual income totaling USD 56.29M.

High Profit Growth

The company's net income leads the industry, with the latest annual income totaling USD 185.51.

Undervalued

The company’s latest PE is 5.91, at a low 3-year percentile range.

Institutional Selling

The latest institutional holdings are 9.46M shares, decreasing 23.54% quarter-over-quarter.

Held by The Vanguard

Star Investor The Vanguard holds 639.47K shares of this stock.

Lower Market Activity

The company has less investor interest, with a 20-day turnover ratio of 0.24.

Financial Health

Currency: USD Updated: 2025-09-18

The company's current financial score is 6.30, which is lower than the Healthcare Equipment & Supplies industry's average of 7.32. Its financial status is weak, and its operating efficiency is high. Its latest quarterly revenue reached 8.22M, representing a year-over-year decrease of 43.19%, while its net profit experienced a year-over-year decrease of 608381.82%.

Score

Industry at a Glance

Previous score

6.30

Change



Financials

5.97

Key Metrics

Cash and cash equivalents

Total assets

Total liabilities

Free cash flow

No Data



Quality of Earnings

6.49

Key Metrics

Total revenue

Operating profit

Total assets

SG&A

No Data



Operational Efficiency

8.30

Key Metrics

Cash flow from operating activities

Income after tax

No Data



Growth Potential

3.60

Key Metrics

Cash flow from operating activities

Total revenue

No Data



Shareholder Returns

7.15

Key Metrics

Free cash flow

No Data

Company Valuation

Currency: USD Updated: 2025-09-18

The company’s current valuation score is 5.89, which is higher than the Healthcare Equipment & Supplies industry's average of 2.00. Its current P/E ratio is 5.55, which is 133.95% below the recent high of 12.98 and -66.32% above the recent low of 9.23.

Score

Industry at a Glance

Previous score

5.89

Change

1.57

Valuation Dimensions

P/E

P/B

P/S

P/CF

Industry Ranking 67/207

No Data

Earnings Forecast

Currency: USD Updated: 2025-09-18

The company’s current earnings forecast score is 8.00, which is higher than the Healthcare Equipment & Supplies industry's average of 7.70. The average price target for Semler Scientific Inc is 95.00, with a high of 101.00 and a low of 60.00.

Score

Industry at a Glance

Previous score

8.00

Change

Support & Resistance

No Data

Analyst Rating

Based on 3 analysts

Buy

Current Rating

85.333

Target Price

+208.29%

Upside Space

Strong Buy

Buy

Hold

Sell

Strong Sell

Peer Comparison

118

Total

Median

Average

Company name

Ratings

Analysts

Semler Scientific Inc

SMLR

Medtronic PLC

MDT

Stryker Corp

SYK

Abbott Laboratories

ABT

Zimmer Biomet Holdings Inc

ZBH

Dexcom Inc

DXCM

...

Financial Forecasting

EPS

Revenue

Net Profit

EBIT

No Data

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Price Momentum

Currency: USD Updated: 2025-09-18

The company’s current price momentum score is 5.98, which is lower than the Healthcare Equipment & Supplies industry's average of 6.45. Sideways: Currently, the stock price is trading between the resistance level at 31.03 and the support level at 25.70, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score

5.98

Change

0.53

Support & Resistance

No Data

Indicators



The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

Indicators

Sell(1)

Neutral(3)

Buy(3)

Indicators

Value

Direction

MACD(12,26,9)

0.614

Neutral

RSI(14)

45.028

Neutral

STOCH(KDJ)(9,3,3)

64.442

Buy

ATR(14)

1.438

High Vlolatility

CCI(14)

64.041

Neutral

Williams %R

33.276

Buy

TRIX(12,20)

-0.809

Sell

StochRSI(14)

100.000

Buy

Moving Average

Sell(3)

Neutral(0)

Buy(3)

Indicators

Value

Direction

MA5

28.772

Buy

MA10

28.490

Buy

MA20

29.227

Buy

MA50

34.400

Sell

MA100

35.583

Sell

MA200

41.919

Sell

Institutional Confidence

Currency: USD Updated: 2025-09-18

The company’s current institutional recognition score is 5.00, which is lower than the Healthcare Equipment & Supplies industry's average of 6.89. The latest institutional shareholding proportion is 64.54%, representing a quarter-over-quarter decrease of 1.09%. The largest institutional shareholder is The Vanguard, holding a total of 639.47K shares, representing 4.32% of shares outstanding, with 34.79% increase in holdings.

Score

Industry at a Glance

Previous score

5.00

Change

Institutional Shareholding

No Data

Shareholder Activity

Name

Shares Held

Chg %

Interchange Capital Partners LLC

1.28M

Chang Family Trust

884.26K

+0.09%

Morgan Stanley Investment Management Inc. (US)

473.10K

+45.61%

Semler (Eric J.D.)

714.12K

+0.95%

Capital International Investors

619.78K

+8.62%

The Vanguard Group, Inc.

Star Investors

440.71K

+43.91%

BlackRock Institutional Trust Company, N.A.

466.81K

+33.61%

Driehaus Capital Management, LLC

186.76K

-0.37%

Risk Assessment

Currency: USD Updated: 2025-09-18

The company’s current risk assessment score is 3.14, which is lower than the Healthcare Equipment & Supplies industry's average of 3.87. The company's beta value is 1.42. This indicates that the stock tends to outperform the index during upward trending markets but experiences larger declines during downward trending markets.